Cargando…
Long-term outcomes of combination photodynamic therapy with ranibizumab or bevacizumab for treatment of wet age-related macular degeneration
AIM: To evaluate and compare the efficacy of combination of ranibizumab or bevacizumab with photodynamic therapy (PDT) in treating choroidal neovascularization (CNV) secondary to age-related macular degeneration (ARMD) on long-term follow-up. MATERIALS AND METHODS: Of 42 eyes, 18 were treated with b...
Autores principales: | Rishi, Ekta, Rishi, Pukhraj, Sharma, Vishal, Koundanya, Vikram, Athanikar, Renu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932801/ https://www.ncbi.nlm.nih.gov/pubmed/27433034 http://dx.doi.org/10.4103/0974-620X.184511 |
Ejemplares similares
-
Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia
por: Rishi, Pukhraj, et al.
Publicado: (2009) -
Photodynamic monotherapy or combination treatment with intravitreal triamcinolone acetonide, bevacizumab or ranibizumab for choroidal neovascularization associated with pathological myopia
por: Rishi, Pukhraj, et al.
Publicado: (2011) -
Combination photodynamic therapy and bevacizumab for choroidal neovascularization associated with toxoplasmosis
por: Rishi, Pukhraj, et al.
Publicado: (2011) -
Combined photodynamic therapy
and intravitreal ranibizumab as
primary treatment for choroidal
neovascularization associated with
age-related macular degeneration in
an Indian patient
por: Rishi, Pukhraj, et al.
Publicado: (2008) -
Foveal atrophy and macular hole formation following intravitreal ranibizumab with/without photodynamic therapy for choroidal neovascularization secondary to age-related macular degeneration
por: Rishi, Pukhraj, et al.
Publicado: (2011)